This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In an era punctuated by school shootings and ongoing debates about gun control and gun rights, America’s public schools continue to be riddled with safety concerns. According to the New York Times, “Since 2017, tens of millions have been spent by the federal government on mass shooter training, and states have spent even more.” The result of our culture’s focus on crisis management over prevention is more security staff in high schools than there are
There is still the potential for 'significant risk' to patient safety in new guidance about online prescribing of weight-loss injections and other high-risk medicines, the Pharmacists' Defence Association (PDA) has said. In particular, it raised concerns that medication might be prescribed inappropriately where a patient does not give consent for their GP to be contacted […] The post Weight-loss jabs: Concerns over 'significant risk' if GP records can't be accessed appeared
A strange thing happened weeks before the Food and Drug Administration approved the first treatment made with CRISPR gene editing , an all-but cure for certain patients with sickle cell disease. CRISPR Therapeutics, the biotech that co-developed the therapy, laid off about 50 employees. “We were dumbfounded,” said a scientist who was let go.
Two batches of nitrofurantoin 100mg prolonged-release capsules have been recalled after a small number of packs were found to contain an additional tablet of nitrofurantoin. Nitrofurantoin is used to treat Urinary Tract Infections (UTIs), and six 100mg modified release capsules can be supplied under the NHS England Pharmacy First Patient Group Direction (PGD) for uncomplicated […] The post Nitrofurantoin recall as extra tablet found in packs of UTI antibiotics appeared first on The Pharmac
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Bringing groundbreaking drugs and therapies to market is critical for the European pharmaceutical industry, yet these businesses face significant hurdles. Intellectual property (IP) management and monetisation is essential to overcoming these challenges, and the introduction of the Unified Patent Court (UPC) offers a centralised system that enhances intellectual property protection, helping companies sustain innovation and maintain a competitive edge.
Following the president’s recent executive order dismantling diversity, equity, and inclusion policies, the main page for the FDA’s Diversity Action Plan guidelines — requiring pharmaceutical companies to test drugs on diverse populations before approval — has been down since Jan. 23. These guidelines were established under the Food and Drug Omnibus Reform Act of 2022 , enacted by Congress to promote inclusivity in clinical tr
The Multi-Billion Dollar Opportunity in Generic Drugs: How to Seize the Moment As a business leader in the pharmaceutical industry, you're likely no stranger to the importance of staying ahead of the curve. One key trend that's been gaining momentum in recent years is the rise of generic drugs. With the patent expiration of many blockbuster medications, the generic drug market is poised for significant growth.
53
53
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
The Multi-Billion Dollar Opportunity in Generic Drugs: How to Seize the Moment As a business leader in the pharmaceutical industry, you're likely no stranger to the importance of staying ahead of the curve. One key trend that's been gaining momentum in recent years is the rise of generic drugs. With the patent expiration of many blockbuster medications, the generic drug market is poised for significant growth.
Top of the morning to you, and a fine one it is. Although chilly outdoors, the freezing rain enveloping the Pharmalot campus makes for a picturesque and soothing landscape. And what better way to enjoy the views than to fire up the coffee kettle for another cup of stimulation? Our choice today is peppermint mocha, which we believe is quite appropriate.
The next generation Kangaroo OMNI enteral feeding pump delivers nutrition and hydration from hospital to home. DUBLIN, Ireland, Feb.4, 2025 – Cardinal Healths innovative new Kangaroo OMNI Enteral Feeding Pump will be launched in Europe, Australia and New Zealand by the first half of 2025, followed by Asia later in the year. It previously launched […] The post Cardinal Healths Kangaroo OMNI Enteral Feeding Pump to launch in new international markets in 2025 appeared first on Pharmafil
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. It’s show-me time for batoclimab, the FcRn-targeting antibody treatment from Immunovant and Roivant Sciences. A consequential Phase 3 study readout is coming before the end of the first quarter.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.
Y ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Good morning health tech readers!
The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or be used in new, multi-drug combinations.
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more earnings today and an in-depth report on the rise and fall of CRISPR companies — take some time today to read it.
Cobenfy, the main asset acquired through Bristol Myers’ $14 billion purchase of Karuna, had $10 million in sales in the fourth quarter and is around 1,000 prescriptions weekly by late January.
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
Explore the clinical trends expected for 2025 - including ADCs, Radiopharmaceuticals, CGTs, AAV, and rare diseases. Stay ahead of the curve with these industry insights.
The pharmaceutical company plans to cut $2 billion in annual expenses by the end of 2027 through “operational efficiencies across multiple areas of the business,” its CFO told analysts on a conference call.
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Funding in the pharma and healthcare sector increased by 191.26 per cent to $300 million in January 2025, up from $103 million in December 2024, according to data from Tracxn. This marks a 430.04 per cent rise compared to the $56.6 million raised in January 2024. Private equity rounds accounted for the majority of the funding, contributing $222.3 million, or 74.2 per cent of the total investments.
The drugmaker’s financial forecasts topped Wall Street’s expectations, reassuring investors after it overestimated demand for its weight loss medicines in January.
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Firm reports leap in profits amid strong sales of cancer, lung and immunology treatments a week after pulling plug on Merseyside investment AstraZeneca has reported a jump in annual profits boosted by strong sales of its cancer, lung and immunology treatments, a week after it decided not to go ahead with a planned 450m investment in Merseyside, prompting a series of recriminations with the government.
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
354 
Let's personalize your content